Navigation Links
Laureate Biopharma Appoints Ann M. Daus, Ph.D. Vice President, Quality
Date:3/16/2011

ite more efficient capture and integration of client data

Dr. Daus has over 20 years of experience, including 15 years of management of quality and technical functions including quality assurance, quality control, protein characterization and methods development.  Prior to Laureate, she served as Vice President of Quality Control & Bioanalytical Sciences for ImClone Systems, Inc., where she built and led this department which supported the manufacture of both pilot plant and commercial biopharmaceuticals.  Earlier in her career, Dr. Daus held the position of Associate Director of QA for Smith Kline Beecham, where she managed QA of bulk biopharmaceutical agents through all phases of clinical development.  Dr. Daus started her career with Johnson & Johnson holding a series of Quality Assurance and Quality Control functions of increasing responsibility including QA Manager in support of commercial parenteral pharmaceuticals and diagnostic products.  She holds a B.S. from Millersville University of Pennsylvania, and earned both an M.S. in Microbiology and a Ph.D. in Microbiology & Molecular Genetics from Rutgers University.

For more information related to Laureate Biopharma's capabilities and ongoing improvements please visit www.LBioS.com.

About Laureate Biopharmaceutical Services, Inc.

Laureate Biopharmaceutical Services, Inc. is a full-service biopharmaceutical contract development and manufacturing organization. Laureate Biopharma's scientists are expert in process development and cGMP production of therapeutic proteins including monoclonal antibodies and Fc-fusion proteins. In addition, the company's portfolio of services includes aseptic filling, cell line development, analytical and stability testing, and regulatory support. Laureate Biopharma has served a global client base from its Princeton, New Jersey facility since 1981 and is a portfolio compan
'/>"/>

SOURCE Laureate Biopharmaceutical Services, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Laureate Pharma to Add More Manufacturing Capacity
2. Laureate Announces Manufacturing Agreement with Tolerx
3. Laureate Pharma Announces Agreement with Tolera Therapeutics, Inc.
4. Laureate Pharma Honored as Emerging Life Sciences Company of the Year
5. Nobel Laureates to Speak at Keystone Symposia RNA Silencing Conference
6. US Oncology Named 2009 Laureate by IDG Computerworld Honors Program
7. Nobel Laureate Lee Hartwell to Retire as President and Director of Fred Hutchinson Cancer Research Center in 2010
8. Laureate Pharma Appoints Daniel E. Leone as Vice President of Business Development
9. Laureate Pharma Elects New Board Member
10. Thomson Reuters Predicts Nobel Laureates
11. Laureate Pharma Welcomes Three New Members to Business Development Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... CollabRx, Inc. (NASDAQ: CLRX), a leading provider ... today announced that it will hold an investor conference ... financial results for the first quarter of fiscal 2015 ... the current fiscal year. , The dial-in number for ... 2014, at 5 p.m. EDT (2 p.m. PDT) is ...
(Date:7/31/2014)... 2014  Smith & Nephew (LSE:SN, NYSE: ... today announced its entry into the forefoot market ... Repair System. Comprised of three separate repair options, ... ligament repair and reconstruction, a metatarsal osteotomy guide, ... (PIP) fusion, also known as hammer toe correction. ...
(Date:7/31/2014)... Calif. (PRWEB) July 31, 2014 Held ... diagnosed patients with an overview of the disease and ... of drug side effects, as well as updates on ... grateful to Dr. Sandy Srinivas for organizing this educational ... of kidney cancer. “Sandy and her colleagues have put ...
(Date:7/31/2014)... The global market for molecular diagnostics ... according to a new study by Grand View Research, ... the subsequent introduction of advanced cancer diagnostic technologies are ... the next six years. Moreover, the growing global base ... coupled with disease triggering lifestyle habits such as smoking ...
Breaking Biology Technology:CollabRx, Inc. Schedules First Quarter Fiscal Year 2015 Financial Conference Call and Business Update 2Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 2Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 3Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 4Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 2Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 3Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 4Molecular Diagnostics Market - Global Industry Size, Share, Trends, Analysis, Players, Opportunity, Outlook and Forecast From 2014 to 2020 5
... potentially reach $1 billion by 2014SEATTLE, March 19 ... and MTA: CTIC) reviewed CTI,s programs in a presentation ... Wednesday, March 18th . Mr. Philips, highlights focused ... non-Hodgkin,s lymphoma (NHL) and OPAXIO for treatment of non-small ...
... (Nasdaq: MEDX ) announced today that it is ... Today & Tomorrow Conference at 11:20 a.m. Eastern Time on ... and will be available in the Investor Relations section of ... of the presentation will be available following the event. About ...
... InterMune, Inc. (Nasdaq: ITMN ) today announced ... (R7227) and the company,s research programs related to the hepatitis ... 44th Annual Meeting of the European Association for the Study ... The abstracts are expected to be available at ...
Cached Biology Technology:Cell Therapeutics Presents Corporate Highlights at Invest Northwest Conference 2Cell Therapeutics Presents Corporate Highlights at Invest Northwest Conference 3InterMune to Present Abstracts on HCV Protease Inhibitor ITMN-191 and HCV Development Program at the EASL Meeting 2InterMune to Present Abstracts on HCV Protease Inhibitor ITMN-191 and HCV Development Program at the EASL Meeting 3
(Date:7/30/2014)... reversible epigenetic processes to regulate its genes, and adapt ... picture of the genome regulation taking place in the ... Genome Biology and illustrates how the truffle deals ... The authors say this may shed light on how ... truffles (Tuber melanosporum), also known as Prigord truffles, have ...
(Date:7/30/2014)... American Chemical Society (ACS) announced today that David L. ... ACS Biomaterials Science & Engineering as editor-in-chief. With ... the new journal will feature high-quality research in the ... or naturally derived materials that interact with living or ... it reflects the tremendous growth in the field of ...
(Date:7/30/2014)... of the Entomological Society of America (ESA) has elected ... election as a Fellow acknowledges outstanding contributions to entomology ... extension, or administration. The following Fellows will be recognized ... which will be held November 16-19, 2014 in Portland, ... a professor with the Department of Plant, Soil and ...
Breaking Biology News(10 mins):How black truffles deal with the jumpers in their genome 2ACS Biomaterials Science & Engineering: Brand-new journal launches in 2015, names editor 2Entomological Society of America recognizes 2014 fellows 2Entomological Society of America recognizes 2014 fellows 3Entomological Society of America recognizes 2014 fellows 4Entomological Society of America recognizes 2014 fellows 5Entomological Society of America recognizes 2014 fellows 6Entomological Society of America recognizes 2014 fellows 7Entomological Society of America recognizes 2014 fellows 8Entomological Society of America recognizes 2014 fellows 9Entomological Society of America recognizes 2014 fellows 10Entomological Society of America recognizes 2014 fellows 11Entomological Society of America recognizes 2014 fellows 12Entomological Society of America recognizes 2014 fellows 13Entomological Society of America recognizes 2014 fellows 14Entomological Society of America recognizes 2014 fellows 15Entomological Society of America recognizes 2014 fellows 16Entomological Society of America recognizes 2014 fellows 17
... antibodies for use in vaccines and cancer medicines, enzymes ... substances can already be produced on a large scale ... met by making use of living cells or organisms. ... the target protein to bacteria, yeasts, or cultures of ...
... hosting a conference for researchers and clinicians on depression, ... Treatment Battlefeld and New Research," on Friday, November 1, ... Icahn School of Medicine at Mount Sinai, The Bonnie ... and 102nd Streets) in New York City. Recent meta-analyses ...
... electricity is hard to come by and scientific instruments are ... medical lab is rarely an option. Scientists are now reporting ... void with no electronics required. Their study on the extremely ... of time, appears in the ACS journal Analytical Chemistry ...
Cached Biology News:Biomolecules for the production line 2Biomolecules for the production line 3Towards a real understanding of depression 2